FDA provides summaries of adverse drug experiences

被引：0
|
作者：
不详
机构：
来源：
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2008年 / 233卷 / 05期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [41] Patients’ experiences on adverse drug reactions reporting: a qualitative study
    Rania Al Dweik
    Sanni Yaya
    Dawn Stacey
    Dafna Kohen
    European Journal of Clinical Pharmacology, 2020, 76 : 1723 - 1730
  • [42] Pharmacists' experiences on adverse drug reaction: 10 years later
    Karuppannan, Mahmathi
    Rizal, Nur Azzrin Nisha Mohamad
    Wong, Kok-Thong
    Ali, Salmiah Mohd
    Ting, Kang-Nee
    Boardman, Helen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Exploring patient experiences of information about adverse drug reactions
    Krska, J.
    Taylor, J.
    Morecroft, C. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 115 - 115
  • [44] Survey of patients’ experiences and their certainty of suspected adverse drug reactions
    Jarernsiripornkul Narumol
    Patsuree Arunrot
    Janet Krska
    International Journal of Clinical Pharmacy, 2015, 37 : 168 - 174
  • [45] Experiences of adverse drug effects reported by patients in ambulatory clinic
    Jarernsiripornkul, Narumol
    Chaipichit, Nataporn
    Krska, Janet
    Uchaipichat, Verawan
    Pratipanawatr, Thongchai
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 213 - 213
  • [46] Extracting adverse drug effects from user experiences: A baseline
    Abrantes, Diogo
    Cordeiro, Joao
    2018 31ST IEEE INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS 2018), 2018, : 405 - 410
  • [47] Parents' experiences of adverse drug reations in children: qualitative study
    Arnott, J.
    Turner, M. A.
    Hesselgreave, H.
    Nunn, A. J.
    Peak, M.
    Pirmohamed, M.
    Smyth, R. L.
    Young, B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 112 - 112
  • [48] Patients' experiences on adverse drug reactions reporting: a qualitative study
    Al Dweik, Rania
    Yaya, Sanni
    Stacey, Dawn
    Kohen, Dafna
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (12) : 1723 - 1730
  • [49] Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS)
    Li, Ruibo
    Yuan, Xingyue
    Chen, Xi
    Ou, Yili
    Chen, Jin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system
    Liu, Xiang
    Wang, Zixin
    Peng, Cong
    Zhou, Jiaming
    Chen, Minggen
    Luo, Longhua
    Sun, Xiang
    EXPERT OPINION ON DRUG SAFETY, 2024,
12345